Millennium Pharmacon International (SDPC) — Cash Flow Reinvestment Rate

Latest as of March 2025: 0.12x

Millennium Pharmacon International (SDPC) has a Cash Flow Reinvestment Rate of 0.12x as of March 2025, reinvesting Rp8.35 Billion (capex Rp1.09 Billion plus investments Rp-7.26 Billion) from operating cash flow of Rp70.29 Billion. See SDPC FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.12x
(Capex + Investments) / Operating CF

Total Reinvested

Rp8.35 Billion
Capex + Investments

Operating Cash Flow

Rp70.29 Billion
IDR

Capital Expenditures

Rp1.09 Billion
IDR

Millennium Pharmacon International Cash Flow Reinvestment Rate (2004–2022)

Historical reinvestment intensity for Millennium Pharmacon International across 8 annual periods. For the full cash flow conversion analysis, see Millennium Pharmacon International (SDPC) cash conversion ratio.

Annual Cash Flow Reinvestment Rate for Millennium Pharmacon International (2004–2022)

Year-by-year capital reinvestment analysis for Millennium Pharmacon International. See Millennium Pharmacon International (SDPC) financial flexibility to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (IDR) Operating CF Capex YoY Change
2022 0.71x Rp29.29 Billion Rp41.00 Billion Rp14.68 Billion ▲ +571.7%
2020 0.11x Rp7.62 Billion Rp71.69 Billion Rp3.81 Billion ▼ -95.9%
2018 2.60x Rp12.30 Billion Rp4.72 Billion Rp6.35 Billion ▼ -80.8%
2017 13.60x Rp60.61 Billion Rp4.46 Billion Rp6.61 Billion ▲ +2287.6%
2012 0.57x Rp1.25 Billion Rp2.19 Billion Rp1.25 Billion ▼ -21.3%
2007 0.72x Rp3.31 Billion Rp4.57 Billion Rp3.31 Billion ▼ -26.7%
2006 0.99x Rp792.17 Million Rp802.62 Million Rp792.17 Million ▲ +59.7%
2004 0.62x Rp1.68 Billion Rp2.72 Billion Rp1.68 Billion
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow